Business Context and Reporting Period
This Form 6-K filing by Hong Kong Pharma Digital Technology Holdings Limited (the "Company") covers the month of September 2025. The report discloses a corporate governance update regarding the appointment of a new independent director effective September 9, 2025.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a personnel appointment and does not contain financial statements or operational metrics.
Material Changes
The primary material change disclosed is the addition of Mr. Zhou Mike Yao to the Board of Directors as an Independent Director and a member of the nomination committee. No financial or operational changes versus prior periods are reported in this document.
Guidance, Outlook, and Management Commentary
- Appointment Details: Mr. Zhou, aged 34, brings experience in investment, capital markets, and corporate development. He currently serves as regional director of Norwich Capital Limited and president of MYZ Corporate Relations Ltd.
- Compensation: The Company agreed to pay Mr. Zhou an annual compensation of HK$100,000, payable in arrears in equal quarterly installments.
- Independence: The Board determined Mr. Zhou meets the definition of an "independent director" under Nasdaq Listing Rule 5605(a)(2). No related party transactions or undisclosed arrangements exist.
- Indemnification: Mr. Zhou is covered under the Company's standard indemnification agreement for officers and directors.
Key Facts for Investor Verification
- Verify the effective date of Mr. Zhou Mike Yao's appointment (September 9, 2025).
- Confirm the annual compensation amount of HK$100,000 and the quarterly payment schedule.
- Review Mr. Zhou's prior board service at Direct Communication Solutions Inc. and Explorex Resource Inc. for potential conflicts of interest.
- Note that this filing contains no financial performance data; investors should refer to the most recent Form 20-F for financial metrics.